LIMPRINT study: The Turkish experience

Basit Öğe Kaydı
dc.contributor.authorBorman P.
dc.contributor.authorMoffatt C.
dc.contributor.authorMurray S.
dc.contributor.authorYaman A.
dc.contributor.authorDenizli M.
dc.contributor.authorDalyan M.
dc.contributor.authorUnsal-Delialioglu S.
dc.contributor.authorEyigör S.
dc.contributor.authorAyhan F.
dc.contributor.authorÇaklt B.D.
dc.contributor.authorVural S.
dc.contributor.authorÖzdemir O.
dc.contributor.authorKurt E.
dc.contributor.authorÇelik E.C.
dc.contributor.authorCerrahoglu L.
dc.contributor.authorKepekçi M.
dc.contributor.authorTerzioglu F.
dc.contributor.authorDonmez A.A.
dc.date.accessioned2019-10-26T21:12:22Z
dc.date.available2019-10-26T21:12:22Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground: Lymphedema and chronic edema is a major health care problem in both developed and nondeveloped countries The Lymphoedema Impact and Prevelance-International (LIMPRINT) study is an international health service-based study to determine the prevalence and functional impact in adult populations of member countries of the International Lymphoedema Framework (ILF). Methods and Results: A total of 1051 patients from eight centers in Turkey were recruited using the LIMPRINT study protocol. Data were collected using the core and module tools that assess the demographic and clinical properties as well as disability and quality of life (QoL). Most of the Turkish patients were recruited from specialist lymphedema services and were found to be women, housewives, and having secondary lymphedema because of cancer treatment. The duration of lymphedema was commonly <5 years and most of them had International Society of Lymphology (ISL) grade 2 lymphedema. Cellulitis, infection, and wounds were uncommon. The majority of patients did not get any treatment or advice before. Most of the patients had impaired QoL and decreased functionality, but psychological support was neglected. Although most had social health security access to lymphedema centers, nevertheless access seemed difficult because of distance and cost. Conclusion: The study has shown the current status and characteristics of lymphedema patients, treatment conditions, the unmet need for the diagnosis and treatment, as well as burden of the disease in both patients and families in Turkey. National health policies are needed for the prevention, diagnosis, and treatment in Turkey that utilize this informative data. © Pinar Borman et al. 2019; Published by Mary Ann Liebert, Inc. 2019.en_US
dc.identifier.doi10.1089/lrb.2019.0015en_US
dc.identifier.endpage210en_US
dc.identifier.issn1539-6851
dc.identifier.issue2en_US
dc.identifier.pmid30995192en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage202en_US
dc.identifier.urihttps://doi.org/10.1089/lrb.2019.0015
dc.identifier.urihttps://hdl.handle.net/11454/15680
dc.identifier.volume17en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert Inc.en_US
dc.relation.ispartofLymphatic Research and Biologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectchronic edemaen_US
dc.subjectimpacten_US
dc.subjectLIMPRINTen_US
dc.subjectlymphedemaen_US
dc.subjectlymphoedemaen_US
dc.subjectquality of lifeen_US
dc.titleLIMPRINT study: The Turkish experienceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu